Remove 2025 Remove BioTech Remove EHR
article thumbnail

HealthTech M&A Multiples March 2025: Current Trends and Variables driving valuations

Lloyd Price

Exec Summary: The HealthTech M&A landscape in 2025 is characterised by a mix of opportunity and caution. The increase of distressed company M&A's is a large factor in the 2025 market. Average revenue multiples The average revenue multiple for HealthTech companies in March 2025 is 4.8x. This is down from 6.5x

article thumbnail

Affineon Secures $5M to Power Physician Productivity

Healthcare IT Today

Seamlessly integrated with electronic health record (EHR) systems, providers reclaim their time in Affineons AI inbox without disrupting existing workflows. Affineon integrates seamlessly with EHR systems, saving providers time and enhancing the healthcare experience. Originally announced February 3rd, 2025

BioTech 52
article thumbnail

Healthcare Startups Shine at Collision 2024

Healthcare IT Today

Innovative startups in the health IT, medical device, and biotech fields were among the shining stars at the annual Collision conference. In 2025 the conference heads to its new home in Vancouver, BC under its new banner – WebSummit Vancouver. The 2024 conference was held in Toronto, ON for the final time.

BioTech 124